News & Press Releases

Mintz advised the placement agents in the $145 million private placement of First Tracks Biotherapeutics’ common stock, which included $80 million of common stock sold by First Tracks Biotherapeutics and $65 million of common stock sold by a selling stockholder. The private placement was in connection with the spin-off of First Tracks Biotherapeutics from AnaptysBio.

Member Theresa Carnegie was quoted in a Corporate Counsel article analyzing the broader impact of a recent pharmacy benefit manager (PBM) settlement and how it may affect health plans going forward.

Amit Singh participated in TechCon SoCal 2026, where Mintz hosted the Startup Innovation Showcase Semifinal in San Diego, bringing together leading founders, investors, and innovators.

Daniel Cody was quoted in a Healthcare Brew article advising physicians on how to assess whether a telemedicine company is operating legitimately before entering into a working relationship.

Of Counsel Michelle Capezza was quoted in a Fiduciary News article examining whether delegating investment discretion to a 3(38)-investment manager meaningfully transfers fiduciary risk or merely creates a false sense of protection for plan sponsors.

New York – Mintz announces the appointment of Francis (Frank) Earley as Managing Member of its New York office. A seasoned litigator, Frank brings extensive experience handling complex commercial and securities disputes. He succeeds Stephen (Steve) Gulotta, who, after successfully leading the office for 17 years, will now focus full time on his role as Member in the firm’s Corporate & Securities Practice based in New York.